U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06917664) titled 'Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease' on March 27.
Brief Summary: This study aims to evaluate the effect of angiotensin receptor/neprilysin inhibitors (ARNI) on improving ischemic mitral regurgitation (IMR) in patients with coronary artery disease undergoing isolated coronary artery bypass grafting (CABG) through a randomized controlled clincial trial.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Coronary Artery Disease
Ischemic Mitral Regurgitation
Angiotensin Receptor/Neprilysin Inhibitor
Intervention:
DRUG: sacubitril/valsartan
Sacubitril/valsar...